Neurosense Therapeutics News - September 4, 2026
🔴 Neurosense Therapeutics is trading 6.05% down in after-hours trading
Neurosense Therapeutics is trading 6.05% down at $0.48, with no clear company-specific announcement or earnings release explaining the after-hours decline. -...
🟢 Neurosense Therapeutics is trading 12.1% up today after HC Wainwright initiated coverage with $8.00 target
Neurosense Therapeutics is trading 12.1% up at $0.45 after HC Wainwright initiated coverage on September 3, 2026, with a Buy rating and an $8.00 price...
🟢 Neurosense Therapeutics is trading 9.56% up today after HC Wainwright initiated Buy-rated coverage
Neurosense Therapeutics is trading 9.56% up now at $0.44 after HC Wainwright initiated coverage on September 3, 2026, with a Buy rating and an $8.00 price...